ICON Public Limited Company (ICLR) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$124.13
Price Target
$149.63
Target Range
$100.00 — $222.00
Analyst Rating
Buy
Forward P/E10.5x
Trailing P/E13.0x
Forward PEG1.49
Implied Growth+54.6%
Median Target$127.00
Analyst Spread81.5%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$100
-19.4%
Consensus
$150
+20.5%
Bull Case
$222
+78.8%
Valuation Model TargetsConfidence: 58/100
Bear$62
Base$139
Bull$355
ICLR Price Target Analysis
Updated May 7, 2026As of May 7, 2026, ICON Public Limited Company (ICLR) has a Wall Street consensus price target of $149.63, based on estimates from 30 covering analysts. With the stock currently trading at $124.13, this represents a potential upside of +20.5%. The company has a market capitalization of $9.48B.
Analyst price targets range from a low of $100.00 to a high of $222.00, representing a 82% spread in expectations. The median target of $127.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 17 analysts rating the stock as a Buy or Strong Buy,12 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ICLR trades at a trailing P/E of 13.0x and forward P/E of 10.5x. The forward PEG ratio of 1.49 indicates reasonable valuation for growth. Analysts expect EPS to grow +54.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $139.41, with bear and bull scenarios of $61.75 and $355.00 respectively. Model confidence stands at 58/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+26.3%
Avg Forward P/E22.5x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CRLCharles River Laboratories International, Inc. | $9.0B | $181.73 | $205.43 | +13.0% | Buy | 16.4x | 36 |
 IQVIQVIA Holdings Inc. | $29.9B | $176.47 | $225.63 | +27.9% | Buy | 13.9x | 44 |
 MEDPMedpace Holdings, Inc. | $12.2B | $426.79 | $498.86 | +16.9% | Hold | 25.1x | 19 |
 PRAProAssurance Corporation | $1.3B | $24.60 | $18.33 | -25.5% | Hold | 21.8x | 11 |
 LHLabcorp Holdings Inc. | $21.1B | $256.93 | $311.33 | +21.2% | Buy | 14.4x | 35 |
 DGXQuest Diagnostics Incorporated | $20.9B | $189.13 | $220.57 | +16.6% | Hold | 17.6x | 34 |
 NVCRNovoCure Limited | $1.9B | $16.50 | $33.50 | +103.1% | Buy | — | 15 |
 HIMSHims & Hers Health, Inc. | $6.9B | $26.88 | $29.67 | +10.4% | Hold | 53.9x | 19 |
 TMOThermo Fisher Scientific Inc. | $175.8B | $472.95 | $654.67 | +38.4% | Buy | 19.0x | 42 |
 DHRDanaher Corporation | $123.8B | $174.92 | $247.00 | +41.2% | Buy | 20.7x | 42 |
Upside Potential Comparison
NVCRDHRTMOIQVLHMEDPDGXCRLSee ICLR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ICLR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ICLR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonICLR — Frequently Asked Questions
Quick answers to the most common questions about buying ICLR stock.
What is the ICLR stock price target for 2026?
The consensus Wall Street price target for ICLR is $149.63, representing 20.5% upside from the current price of $124.13. With 30 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is ICLR a buy, sell, or hold?
ICLR has a consensus rating of "Buy" based on 30 Wall Street analysts. The rating breakdown is predominantly bullish, with 17 Buy/Strong Buy ratings. The consensus 12-month price target of $149.63 implies 20.5% upside from current levels.
Is ICLR stock overvalued or undervalued?
With a forward P/E of 10.4547x, ICLR trades at a relatively low valuation. The consensus target of $149.63 implies 20.5% appreciation, suggesting meaningful undervaluation.
How high can ICLR stock go?
The most bullish Wall Street analyst has a price target of $222 for ICLR, while the most conservative target is $100. The consensus of $149.63 represents the median expectation. Our quantitative valuation model projects a bull case target of $355 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover ICLR stock?
ICLR is heavily covered by Wall Street, with 30 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 17 have Buy ratings, 12 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ICLR stock forecast?
The 12-month ICLR stock forecast based on 30 Wall Street analysts shows a consensus price target of $149.63, with estimates ranging from $100 (bear case) to $222 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $139, with bear/bull scenarios of $62/$355.
What is ICLR's fair value based on fundamentals?
Our quantitative valuation model calculates ICLR's fair value at $139 (base case), with a bear case of $62 and bull case of $355. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 58/100.
What is ICLR's forward P/E ratio?
ICLR trades at a forward P/E ratio of 10.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 13.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ICLR stock?
Wall Street analysts are very optimistic on ICLR, with a "Buy" consensus rating and $149.63 price target (20.5% upside). 17 of 30 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ICLR price targets vary so much?
ICLR analyst price targets range from $100 to $222, a 82% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $149.63 consensus represents the middle ground. Our model's $62-$355 range provides an independent fundamental perspective.